Gauzy (GAUZ) announced changes to its Board of Directors following the Company’s annual general meeting of shareholders. The shareholders of the Company have elected longtime company investor and former Board member Alejandro Weinstein, to return to the Board as a Director with his term commencing November 1, 2025. Weinstein previously served as CEO of CFR Pharmaceuticals. Gal Gitter concluded his service on the Board following the expiration of his term as a Class I Director. In addition, long-time Director and Board member, Danny Allouche is stepping down from the Board.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GAUZ: